Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 31.0B | 25.9B | 24.6B | 31.3B |
Cost of revenue | 22.9B | 19.8B | 16.7B | 25.0B |
Gross profit | 8.1B | 6.1B | 7.9B | 6.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 740.8M | 808.7M | 2.4B | 1.1B |
Operating income | 5.7B | 3.9B | 4.1B | 3.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 3.1B | 3.2B | 3.2B | 3.0B |
Other income expense | — | — | — | — |
Pretax income | 3.5B | 2.1B | 3.1B | 1.1B |
Tax provision | 736.1M | 507.9M | 430.8M | -263.0M |
Net income | 2.8B | 1.6B | 2.7B | 1.4B |
Basic EPS | — | 10.8 | 18.2 | 9.6 |
Diluted EPS | — | 9.7 | 16.4 | 9.3 |
Basic average shares | — | 106.9M | 129.4M | 125.0M |
Diluted average shares | — | 118.7M | 143.6M | 128.6M |
EBITDA | 7.1B | 5.2B | 5.6B | 5.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | -1.1B | -424.0M | -306.2M | -202.8M |
Preferred stock dividends | 0 | 0 | 0 | 0 |